| Heading: |
Care Homes and Palliative Care: Drugs |
| Question ID: |
1798786 |
| UIN: |
49330 |
| House: |
Commons |
| Date tabled: |
2025-04-30 |
| Asking Member ID: |
1521 |
| Asking Member display name: |
Mrs Sharon Hodgson
|
| Asking Member handle: |
SharonHodgsonMP
|
| Asking Member Twitter reference: |
@SharonHodgsonMP
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential impact of controls on stocking (a) palliative care medicines and (b) controlled drugs on the (i) adequacy of access to medication for patien |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-05-08 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4359 |
| Answering Member display name: |
Stephen Kinnock
|
| Answering Member handle: |
skinnock
|
| Answering Member Twitter reference: |
@skinnock
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
Under the Enhanced health in care homes framework, every care home must be aligned to a primary care network (PCN) and must have established protocols between the PCN, the care home, and system partners, such as local general practices and pharmacies, for... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |